SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-007752
Filing Date
2014-02-05
Accepted
2014-02-05 19:30:27
Documents
2
Period of Report
2014-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4076
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4458
  Complete submission text file 0001209191-14-007752.txt   9932
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
Tubridy Karen L (Reporting) CIK: 0001589888 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 14577633